Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells

Dwain L Thiele, S. E. Bryde, P. E. Lipsky

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Treatment of C57BL/6J (B6) murine splenocytes with L-leucyl-L-leucine methyl ester (Leu-Leu-OMe) selectively removes NK cells, CTL precursors, and the capacity to cause lethal graft-vs-host disease (GVHD) in irradiated B6 x DBA/2 F1 mice. In contrast, alloantigen-induced L3T4(+) Th cell function has been shown to be relatively preserved after exposure to this agent. The present studies assessed the effects of Leu-Leu-OMe treatment of donor cells on induction of lethal GVHD in other murine strain combinations. When irradiated B6 x CBAF1 mice were infused with T and NK cell-depleted B6 bone marrow cells and 3 to 30 x 106 B6 spleen cells uniformly lethal GVHD was observed. However, B6 x CBAF1 recipients of T and NK-depleted B6 bone marrow cells and similar numbers of Leu-Leu-OMe-treated B6 spleen cells demonstrated 90 to 100% long term survival. In contrast, Leu-Leu-OMe treatment of B6 donor cells had no beneficial effect on mortality rates in irradiated (B6 x B6-C-H-2bm12)F1 (B6 x bm12F1) recipients. When B6 spleen cells were stimulated in vivo or in vitro with either B6 x CBAF1 or B6 x bm12F1 stimulator cells, the capacity to generate alloantigen-specific CTL was abolished comparably by Leu-Leu-OMe treatment. Thus, the dramatic difference between the effects of Leu-Leu-OMe treatment of B6 spleen cells on the course of GVHD in B6 x CBAF1 and class II MHC only disparate B6 x bm12F1 recipients could not be explained by unique resistance of bm 12-specific CTL precursors to Leu-Leu-OMe. These findings indicate that T cell effector mechanisms distinct from classic cell-mediated cytotoxicity are sufficient to generate lethal GVHD in class II MHC only disparate B6 → B6 x bm12F1 mice.

Original languageEnglish (US)
Pages (from-to)3377-3382
Number of pages6
JournalJournal of Immunology
Volume141
Issue number10
StatePublished - 1988

Fingerprint

Histocompatibility Antigens Class II
Graft vs Host Disease
T-Lymphocytes
Spleen
Isoantigens
Natural Killer Cells
Bone Marrow Cells
leucylleucine
leucyl-leucine-methyl ester
Cell Count
Mortality

ASJC Scopus subject areas

  • Immunology

Cite this

Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells. / Thiele, Dwain L; Bryde, S. E.; Lipsky, P. E.

In: Journal of Immunology, Vol. 141, No. 10, 1988, p. 3377-3382.

Research output: Contribution to journalArticle

@article{ee4e044b940240d4a523c2d10a5b2b9a,
title = "Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells",
abstract = "Treatment of C57BL/6J (B6) murine splenocytes with L-leucyl-L-leucine methyl ester (Leu-Leu-OMe) selectively removes NK cells, CTL precursors, and the capacity to cause lethal graft-vs-host disease (GVHD) in irradiated B6 x DBA/2 F1 mice. In contrast, alloantigen-induced L3T4(+) Th cell function has been shown to be relatively preserved after exposure to this agent. The present studies assessed the effects of Leu-Leu-OMe treatment of donor cells on induction of lethal GVHD in other murine strain combinations. When irradiated B6 x CBAF1 mice were infused with T and NK cell-depleted B6 bone marrow cells and 3 to 30 x 106 B6 spleen cells uniformly lethal GVHD was observed. However, B6 x CBAF1 recipients of T and NK-depleted B6 bone marrow cells and similar numbers of Leu-Leu-OMe-treated B6 spleen cells demonstrated 90 to 100{\%} long term survival. In contrast, Leu-Leu-OMe treatment of B6 donor cells had no beneficial effect on mortality rates in irradiated (B6 x B6-C-H-2bm12)F1 (B6 x bm12F1) recipients. When B6 spleen cells were stimulated in vivo or in vitro with either B6 x CBAF1 or B6 x bm12F1 stimulator cells, the capacity to generate alloantigen-specific CTL was abolished comparably by Leu-Leu-OMe treatment. Thus, the dramatic difference between the effects of Leu-Leu-OMe treatment of B6 spleen cells on the course of GVHD in B6 x CBAF1 and class II MHC only disparate B6 x bm12F1 recipients could not be explained by unique resistance of bm 12-specific CTL precursors to Leu-Leu-OMe. These findings indicate that T cell effector mechanisms distinct from classic cell-mediated cytotoxicity are sufficient to generate lethal GVHD in class II MHC only disparate B6 → B6 x bm12F1 mice.",
author = "Thiele, {Dwain L} and Bryde, {S. E.} and Lipsky, {P. E.}",
year = "1988",
language = "English (US)",
volume = "141",
pages = "3377--3382",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "10",

}

TY - JOUR

T1 - Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells

AU - Thiele, Dwain L

AU - Bryde, S. E.

AU - Lipsky, P. E.

PY - 1988

Y1 - 1988

N2 - Treatment of C57BL/6J (B6) murine splenocytes with L-leucyl-L-leucine methyl ester (Leu-Leu-OMe) selectively removes NK cells, CTL precursors, and the capacity to cause lethal graft-vs-host disease (GVHD) in irradiated B6 x DBA/2 F1 mice. In contrast, alloantigen-induced L3T4(+) Th cell function has been shown to be relatively preserved after exposure to this agent. The present studies assessed the effects of Leu-Leu-OMe treatment of donor cells on induction of lethal GVHD in other murine strain combinations. When irradiated B6 x CBAF1 mice were infused with T and NK cell-depleted B6 bone marrow cells and 3 to 30 x 106 B6 spleen cells uniformly lethal GVHD was observed. However, B6 x CBAF1 recipients of T and NK-depleted B6 bone marrow cells and similar numbers of Leu-Leu-OMe-treated B6 spleen cells demonstrated 90 to 100% long term survival. In contrast, Leu-Leu-OMe treatment of B6 donor cells had no beneficial effect on mortality rates in irradiated (B6 x B6-C-H-2bm12)F1 (B6 x bm12F1) recipients. When B6 spleen cells were stimulated in vivo or in vitro with either B6 x CBAF1 or B6 x bm12F1 stimulator cells, the capacity to generate alloantigen-specific CTL was abolished comparably by Leu-Leu-OMe treatment. Thus, the dramatic difference between the effects of Leu-Leu-OMe treatment of B6 spleen cells on the course of GVHD in B6 x CBAF1 and class II MHC only disparate B6 x bm12F1 recipients could not be explained by unique resistance of bm 12-specific CTL precursors to Leu-Leu-OMe. These findings indicate that T cell effector mechanisms distinct from classic cell-mediated cytotoxicity are sufficient to generate lethal GVHD in class II MHC only disparate B6 → B6 x bm12F1 mice.

AB - Treatment of C57BL/6J (B6) murine splenocytes with L-leucyl-L-leucine methyl ester (Leu-Leu-OMe) selectively removes NK cells, CTL precursors, and the capacity to cause lethal graft-vs-host disease (GVHD) in irradiated B6 x DBA/2 F1 mice. In contrast, alloantigen-induced L3T4(+) Th cell function has been shown to be relatively preserved after exposure to this agent. The present studies assessed the effects of Leu-Leu-OMe treatment of donor cells on induction of lethal GVHD in other murine strain combinations. When irradiated B6 x CBAF1 mice were infused with T and NK cell-depleted B6 bone marrow cells and 3 to 30 x 106 B6 spleen cells uniformly lethal GVHD was observed. However, B6 x CBAF1 recipients of T and NK-depleted B6 bone marrow cells and similar numbers of Leu-Leu-OMe-treated B6 spleen cells demonstrated 90 to 100% long term survival. In contrast, Leu-Leu-OMe treatment of B6 donor cells had no beneficial effect on mortality rates in irradiated (B6 x B6-C-H-2bm12)F1 (B6 x bm12F1) recipients. When B6 spleen cells were stimulated in vivo or in vitro with either B6 x CBAF1 or B6 x bm12F1 stimulator cells, the capacity to generate alloantigen-specific CTL was abolished comparably by Leu-Leu-OMe treatment. Thus, the dramatic difference between the effects of Leu-Leu-OMe treatment of B6 spleen cells on the course of GVHD in B6 x CBAF1 and class II MHC only disparate B6 x bm12F1 recipients could not be explained by unique resistance of bm 12-specific CTL precursors to Leu-Leu-OMe. These findings indicate that T cell effector mechanisms distinct from classic cell-mediated cytotoxicity are sufficient to generate lethal GVHD in class II MHC only disparate B6 → B6 x bm12F1 mice.

UR - http://www.scopus.com/inward/record.url?scp=0023804206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023804206&partnerID=8YFLogxK

M3 - Article

C2 - 3053897

AN - SCOPUS:0023804206

VL - 141

SP - 3377

EP - 3382

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 10

ER -